Abstract We investigated the characteristics of the new criteria for diabetes mellitus (DM) issued by the Japan Diabetes Society in 2010, which include HbA 1C measurement, and differences between 1999 criteria, in order to indicate clinical caution points. If a person with fasting plasma glucose (FPG) C126 mg/dl or an oral glucose tolerance test (OGTT) 2-h value C200 and HbA 1C C6.5 % is determined as having DM, the disease can be detected at a rate of C70 % in persons \60 years and at no more than 40-50 % in elderly persons. In longitudinal examination, we observed that individuals with DM with FPG C126 mg/ dl and HbA 1C C6.5 % obtained the same determination over time at a rate of nearly 90 %. The percentage of persons whose result shifted from normal type to DM was 3-to 4-fold lower than that of persons whose result shifted from normal type to diabetic type. Based on these results, measurement of FPG and HbA 1C at the same time may be extremely effective in identifying DM, although we should pay attention to a higher likelihood that mild glucose metabolism disorders will be overlooked.
Introduction
In 2009, the International Expert Committee recommended the use of hemoglobin A 1C (HbA 1C ) in the diagnosis of diabetes mellitus (DM) [1] . It became prevalent across the world, leading to the inclusion of HbA 1C in the diagnostic criteria of the American Diabetes Association, European Association for the Study of Diabetes, and World Health Organization [2, 3] . In Japan, a report on classification and diagnostic criteria for DM issued in 1999 was used until the revision [4] . New criteria for DM were proposed in 2010 stating that following a fasting plasma glucose (FPG) level, 2-h oral glucose tolerance test (OGTT) results, or a causal plasma glucose level indicating a diabetic type, and based on HbA 1C C6.5 %, individuals can be diagnosed as having DM [5] . Criteria are evidenced from the association between HbA 1C and FPG or OGTT 2-h value, as well as frequency and incidence of retinopathy [6] . Our purpose was to investigate characteristics of the new criteria for DM issued by the Japan Diabetes Society in 2010-which include HbA 1C levels-and differences between criteria in 1999, to indicate clinical caution points.
Materials and methods
As shown in Table 1 , 11,958 participants comprised men and women with a mean [standard deviation (SD)] of 63.4 ± 9.2. Men were 61.9 ± 9.3 years old; females were 64.7 ± 8.9 years old.
Study participants were a fixed population of atomic bomb survivors in Hiroshima who were born before May 1946. They had been receiving periodic health examinations based on medical law. Blood pressure was measured in a sitting position using the right arm, and all received . Plasma glucose was determined using the glucose oxidase method and venous blood. Triglycerides were measured using an enzymatic method.
Immunoreactive insulin (IRI) was measured with a radioimmunoassay using a double-antibody method. Insulin resistance was evaluated using homeostasis model assessment-estimated insulin resistance (HOMA-IR) and calculated as fasting insulin (lU/ml)/(22.5e lnglucose ) [7] . We used diagnostic criteria for DM issued by the Japan Diabetes Society in 2010 and determined persons with an FPG level C126 mg/dl or an OGTT 2-h value C200 mg/dl and HbA 1C \6.5 % as the diabetic type, and persons with an FPG level C126 mg/dl or an OGTT 2-h value C200 mg/ dl and HbA 1C C6.5 % as having DM.
In longitudinal examination, we observed an OGTT value and HbA 1C in persons who had an initial OGTT value indicating DM. In addition, the percentage of persons whose result shifted from normal type to DM or to diabetic type was expressed as 1000 persons per year. We examined hazard ratios (HR) for the diabetic type and DM development using Cox regression model. The average follow-up duration was 9.7 years; average frequency of OGTT was 2.39 times per person. As the identification of individuals was not used, their information was protected. SAS (JMP) was employed in the statistical analysis, and a comparison of differences was made using t test or chi-square test. A p value \0.05 was considered to indicate statistical significance.
Results
Rate of HbA1 ‡6.5 % in persons with FPG ‡126 mg/dl or 2-h value ‡200 mg/dl Table 2 shows the rates of HbA 1C C6.5 in 2032 persons with FPG C126 mg/dl or 2-h value C200 mg/dl among those undergoing health examinations. The majority of those showing HbA 1C C6.5 % (822; 43.4 %) met the criterion for FPG C126 mg/dl and a 2-h value C200 mg/dl; 138 persons (14.7 %) were detected with the 2-h value alone, and only 65 (6.9 %) were determined with FPG alone. The rate of either FPG C126 mg/dl or 2-h value C200 mg/dl and HbA 1C C6.5 % (A ? B ? C in Table 2 ) was[70 % in those\60 years (A ? B ? C/D in Table 2 ). However, this rate decreased with age to 40-50 % in those aged C60 years.
Meanwhile, the majority of the 947 persons showing HbA 1C \6.5 % had an COGTT 2-h value C200 [862 persons (91.3 %); A 0 ? B 0 in Table 2 ] and were C60 years. Table 3 shows OGTT follow-up results of 1445 persons whose OGTT values were observed. Overall, 86.0 % of them showed FPG C126 mg/dl and HbA 1C C6.5 % at the initial visit and at follow-up were determined as showing the same result; according to age group, the percentage of those aged C80 years was 76.2 %, being slightly lower. Results shifted to the diabetic type in 136 persons (9.4 %) and to normal type in 67 (4.6 %).
Rate and hazard ratio for diabetic type and DM development
Upon longitudinal examination, we compared rates of development between persons with normal type to diabetic type and normal type to DM (Fig. 1) . For FPG \100 mg/ dl, the rates of diabetic type and DM were 19.5 and 4.8 per 1000 person per years, respectively, with the latter being only four times smaller than the former. For an FPG level of 100-109 mg/dl, rates were 34.6 and 8.9 per 1000 persons per year, respectively. Furthermore, for an FPG level of 110-125 mg/dl, rates were 68.8 and 21.1 per 1000 persons per year, respectively. The between-group difference was 4.1-3.3 times, indicating a decrease with an increased FPG level.
We examined HRs for the diabetic type and DM development (Table 4 ). Significant factors were age, FPG, OGTT 2-h value, obesity with body mass index (BMI) C25 kg/m 2 , and hypertriglyceridemia. Only HOMA-IR was a significant factor for DM. 
Discussion
In this study, we investigated the characteristics of the new criteria for DM issued by the Japan Diabetes Society in 2010, which combine HbA 1C , and the differences between 1999 criteria, to indicate clinical caution points. This is the first study employing OGTT in a large population and investigating results based on diagnostic criteria crosssectionally and longitudinally. Data from Table 2 indicate that if a person with FPG C126 mg/dl or OGTT 2-h value C200 and HbA 1C C6.5 % is determined as having DM, the disease can be detected at a rate of C70 % in persons \60 years and no more than 40-50 % in elderly persons. Among persons with HbA 1C \6.5 %, those C60 years accounted for 91.3 %, and the majority of them showed OGTT 2-h value C200. Table 2 Rates of hemoglobin (Hb)A 1C C6.5 in persons with fasting plasma glucose (FPG) C126 mg/dl or 2-h value C200 mg/dl
2-h value C200 C200 \200 C200 C200 \200 Elderly people reportedly have an increased OGTT 2-h value compared with a FPG level. This seems to involve atrophy and dysfunction of the muscles and liver, which primarily metabolize loaded glucose. This result suggests that we may need to not only measure the FPG level but also conduct an OGTT for elderly people. In addition, in terms of whether the condition involving HbA 1C \6.5 % and OGTT 2-h value C200 mg/dl is meaningful, we should observe the frequency of coronary disease and retinopathy.
As shown in Table 4 , the study revealed a high HR of FPG for DM. This suggests that FPG is closely associated with HbA 1C . There is the evidence that, with poorer daytime postprandial glycemic control, nocturnal PG level deteriorates in a stepwise manner, resulting in aggravated diabetes [8] . DM can refer to a state involving a more advanced glucose intolerance compared with the diabetic type. Also, HOMA-IR was a significant factor for DM but not for the diabetic type. Therefore, DM was associated with insulin resistance, but the association between diabetic type and insulin resistance was not clear.
It may not be surprising that discordance exists between OGTT and HbA 1C , since both have a different meaning: the latter is considered to reflect plasma glucose levels for the prior 1 month at a percentage of 50 %, 1-2 months at 25 %, and 2-4 months at 25 % [9] , which is markedly different from OGTT, which reflect the latest glucose tolerance result.
As shown in Fig. 1 , the rates of DM development in those whose result shifted from normal type to DM was 3-to 4-fold lower than that of persons whose result shifted from normal type to the diabetic type. According to this result, it would be difficult to detect persons with mild glucose metabolism disorders. The prevention of DM is desirable from the early stage. Reportedly, when examining screening accuracy for the diabetic type based on HbA 1C C6.5 % in 36,267 persons undergoing health examinations, sensitivity and specificity were 54.3 and 94.6 %, respectively [6] , indicating that, unsurprisingly, all diabetic type persons cannot be detected, including those who have mild glucose metabolism disorders.
In addition, as shown in Table 3 , when temporally observing persons who have FPG or OGTT 2-h value and HbA 1C levels indicating DM, nearly 90 % showed the same result at follow-up. The percentage of persons shifting from DM to normal type was 14.3 % in those 80 years old but 0 % in those 40 years and 4 % in those 50-79 years. According to this finding, measurement of FPG and HbA 1C at the same time may be extremely effective in identifying persons with DM. As DM does not return to normal type, it can refer to a state involving a more advanced glucose intolerance. Furthermore, diagnostic criteria for DM include apparent retinopathy and subjective symptoms. However, these inclusions will have no marked impact on data, since retinopathy is not observed when first diabetes develops and occurs infrequently.
In this study, we investigated the characteristics of the new criteria for DM issued by the Japan Diabetes Society in 2010-which include HbA 1C measurement-and differences between criteria in 1999, to indicate clinical caution points. If a person with FPG C126 mg/dl or 2-h value C200 and HbA 1C C6.5 % is determined as having DM, this disease can be detected at a rate of 70 % or above in persons younger than 60 years and at no more than 40-50 % in elderly persons. The rates of diabetes development whose result shifted from normal type to DM was 3-to 4-fold lower than that of persons whose result shifted from normal type to the diabetic type. When temporally observing the persons who have FPG or 2-h value and HbA 1C indicating the DM, nearly 90 % of these persons were determined as showing the same result at follow-up. Thus, given the significantly decreased rate of DM determined when combining HbA 1C of C6.5 %, we should pay attention to a higher likelihood of overlooking mild glucose metabolism disorders.
This study was supported by a grant-in-aid from the Japan Diabetes Society for the Study on verification of the diagnostic criteria for diabetes mellitus.
Compliance with ethical standards
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1964 and later revision. Informed consent or substitute for it was obtained from all patients for being included in the study. 
